GlassScriptPhysician profile
Joshua Rock
NPI 1285165787
$9,012.83
in general payments reported to CMS, 2019-2025
20 companies · $226 in 2025
The $226 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,542 · 2022: $3,548 · 2023: $819 · 2024: $2,878 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,121 · Travel and Lodging: $1,803.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,120.74 |
| Travel and Lodging | $1,802.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,589.64 | 2021-2024 | Proclaim |
| Medtronic, INC. | $979.52 | 2021-2024 | Intellis Adaptivestim |
| Nevro Corp. | $638.04 | 2021-2024 | Senza |
| Painteq LLC | $614.87 | 2022-2024 | Painteq |
| Abbvie INC. | $304.08 | 2022-2025 | Ubrelvy, Qulipta |
| Averitas Pharma INC. | $173.64 | 2023-2025 | Qutenza |
| Boston Scientific Corporation | $152.32 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Globus Medical, INC. | $103.28 | 2025 | Vyrsa V1 |
| Depuy Synthes Sales INC. | $93.02 | 2022-2025 | Confidence Spinal Cement System |
| Pfizer INC. | $88.05 | 2023 | |
| Novartis Pharmaceuticals Corporation | $65.09 | 2024 | |
| Spr Therapeutics, INC | $52.00 | 2022 | |
| Lilly USA, LLC | $35.24 | 2023 | Emgality, Reyvow |
| Silk Road Medical, INC. | $23.60 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Vertos Medical, INC. | $22.26 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $17.35 | 2022 | |
| Novo Nordisk INC | $17.18 | 2023 | Saxenda |
| Vertex Pharmaceuticals Incorporated | $15.06 | 2024 | |
| Ironwood Pharmaceuticals, INC | $14.71 | 2024 | |
| Avanos Medical | $13.88 | 2023 | Coolief* Cooled Radiofrequency |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Rock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.